Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-10-23
1991-12-10
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 5142285, 5142328, 514254, 514287, 514293, 514322, 540575, 540596, 540597, 540599, 544 581, 544 586, 544 60, 544 61, 544125, 544126, 544361, 546 64, 546 83, 546199, A61K 31495, A61K 3154, A61K 31535, A61K 3155
Patent
active
050718487
ABSTRACT:
Isothiazolo-quinoline derivatives are described which are cytotoxic for various tumor cell lines and are useful in the treatment of neoplastic diseases.
REFERENCES:
patent: 4767762 (1988-08-01), Chu
patent: 4880814 (1989-11-01), Chu et al.
R. B. Lock et al., Anti Cancer Drug Design (1987), 2, 151-164.
Peter D'Arpa et al., Biochimica et Biophysica Acta. 989 (1989) 163-177.
Lui, Annu. Rev. Biochem. 1989, 58-351-75.
Phillips et al., Drug Reviews, Clinical Pharmacy, vol. 2, 1983, pp. 112-119.
Chu Daniel Tim-Wo
Klein Larry L.
Plattner Jacob J.
Shen Linus L.
Abbott Laboratories
Danckers Andreas M.
Shen Cecilia
Weinstock Steven F.
LandOfFree
Tricyclic quinoline antineoplastic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic quinoline antineoplastic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic quinoline antineoplastic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040797